Shares of cannabis companies were broadly higher Tuesday, with the sector headed for a sixth-straight gain, as investors wait for election results to see if two more states–Michigan and North Dakota–will make recreational marijuana legal. The ETFMG Alternative Harvest ETF MJ, +4.21% ran up 4.0%, with 25 of 37 components trading higher. It has gained 19% amid a six-session win streak. The Horizons Marijuana Life Sciences ETF HMMJ, +4.99% hiked up 4.9%. Among the sector’s more-active stocks, Aurora Cannabis Inc. ACB, +3.95% surged 3.3%, Canopy Growth Corp. CGC, +9.38% rose 8.8%, Cronos Group Inc. CRON, +14.37% soared 13% and Tilray Inc. TLRY, +5.38% rallied 5.6%. Shares of GW Pharmaceuticals PLC GWPH, -0.65% slipped 0.8%, although Morgan Stanley reiterated its overweight rating and price target of $227, which was 59% above current levels. Analyst David Lebowitz expects strong demand for Epidiolex, the first cannabis-based drug on the market approved by the Food and Drug Administration, with sales expected to be recorded starting in the fourth quarter. The ETFMG ETF has rallied 30% over the past three months, while the S&P 500 SPX, +0.53% has lost 3.5%.
Have breaking news sent to your inbox. Subscribe to MarketWatch’s free Bulletin emails. Sign up here.